Cargando…
E3 Ubiquitin Ligase NEDD4 Affects Estrogen Receptor α Expression and the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer
SIMPLE SUMMARY: Hormone therapy for breast cancer targets estrogen receptors to inhibit the growth of cancer cells. We previously reported that neural precursor cell-expressed developmentally downregulated 4–1 (NEDD4) promotes the degradation of the estrogen receptor α. Therefore, NEDD4 may affect t...
Autores principales: | Natori, Yutaka, Suga, Junko, Tokuda, Emi, Tachibana, Kazunoshin, Imai, Jun-ichi, Honma, Reiko, Azami, Yusuke, Noda, Masaru, Sasaki, Eisaku, Watanabe, Shinya, Ohtake, Tohru, Saji, Shigehira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857178/ https://www.ncbi.nlm.nih.gov/pubmed/36672488 http://dx.doi.org/10.3390/cancers15020539 |
Ejemplares similares
-
Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab
por: Natori, Yutaka, et al.
Publicado: (2020) -
Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β
por: Murakami-Nishimagi, Yuko, et al.
Publicado: (2023) -
Challenges and future directions in breast cancer care in Fukushima prefecture in Japan: correspondence to “A survey on the current status of clinical resources for diagnosis and treatment of breast cancer in rural hospitals of the Tohoku region in Japan”
por: Ozaki, Akihiko, et al.
Publicado: (2021) -
Correction to: Challenges and future directions in breast cancer care in Fukushima prefecture in Japan: correspondence to “A survey on the current status of clinical resources for diagnosis and treatment of breast cancer in rural hospitals of the Tohoku region in Japan”
por: Ozaki, Akihiko, et al.
Publicado: (2021) -
Estradiol promotes rapid degradation of HER3 in ER-positive breast cancer cell line MCF-7
por: Suga, Junko, et al.
Publicado: (2018)